Valuation: Balaxi Pharmaceuticals Limited

Market Cap 1.23B 12.81M 11.38M 10.61M 9.67M 18.25M 18.42M 129M 49.87M 629M 48.08M 47.04M 2.02B P/E 2025
14.1x
P/E 2026 61.1x
Enterprise Value 1.64B 17.08M 15.18M 14.15M 12.9M 24.33M 24.56M 171M 66.49M 839M 64.11M 62.72M 2.7B EV / Sales 2025
1.16x
EV / Sales 2026 0.47x
Free-Float
90.84%
Yield 2025 *
-
Yield 2026 -
1 day-1.93%
1 week-2.10%
Current month-1.93%
1 month-10.68%
3 months-7.42%
6 months+5.78%
Current year-16.86%
1 week 21
Extreme 21
23.45
1 month 21
Extreme 21
26.6
Current year 15.2
Extreme 15.2
29.9
1 year 15.2
Extreme 15.2
45.31
3 years 15.2
Extreme 15.2
151.45
5 years 15.2
Extreme 15.2
151.45
10 years 2.58
Extreme 2.58
216.04
Manager TitleAgeSince
Chief Executive Officer 56 03/05/2017
Director of Finance/CFO - 19/05/2021
Compliance Officer - 24/03/2026
Director TitleAgeSince
Chairman 56 03/05/2017
Director/Board Member 54 -
Director/Board Member 44 03/05/2017
Change 5-day change 1-year change 3-year change Capi.($)
-1.93%-2.10%-49.83%-75.02% 12.83M
-0.61%-3.43%+39.40%+112.31% 1,019B
-1.02%-5.60%+37.67%+65.02% 617B
+1.11%-0.58%+11.10%+77.28% 464B
+0.34%-3.01%+61.21%+40.71% 356B
-0.95%-4.05%+21.60%+39.37% 333B
-1.46%-2.89%+11.84%+24.60% 267B
-1.35%-5.43%-4.69%+8.40% 244B
-1.04%-2.79%+35.52%+51.34% 218B
-1.87%-4.10%+30.92%+95.33% 179B
Average -0.88%-3.22%+19.47%+43.94% 369.72B
Weighted average by Cap. -0.60%-3.33%+30.52%+68.96%

Financials

2025 2026
Net sales 2.93B 30.38M 27M 25.17M 22.94M 43.29M 43.69M 305M 118M 1.49B 114M 112M 4.8B 2.7B 28.05M 24.94M 23.24M 21.19M 39.98M 40.35M 282M 109M 1.38B 105M 103M 4.43B
Net income 251M 2.6M 2.31M 2.16M 1.97M 3.71M 3.74M 26.14M 10.14M 128M 9.77M 9.56M 411M 14.17M 147K 131K 122K 111K 210K 212K 1.48M 573K 7.23M 552K 540K 23.23M
Net Debt 127M 1.32M 1.17M 1.09M 998K 1.88M 1.9M 13.27M 5.14M 64.87M 4.96M 4.85M 209M 411M 4.27M 3.79M 3.54M 3.22M 6.08M 6.14M 42.87M 16.62M 210M 16.02M 15.68M 674M
Logo Balaxi Pharmaceuticals Limited
Balaxi Pharmaceuticals Limited is an India-based company. The Company operates as an intellectual property right (IPR)-based pharmaceutical company. The Company primarily operates in frontier markets across the Americas, Africa and the Caribbean islands. The Company is focusing on frontier markets, with a growing portfolio of drugs across multiple therapeutic segments. It is engaged in International Wholesale Distribution of Pharmaceuticals. The Company’s products include Anti-biotic, Analgesic, Medical Device, Vitamins, Anti-Malaria, Erectile Dysfunction, Hypertension, Anti-Asthma, Steroid, Anti-Helminthic, Anti-Ulcer, Hygiene, Anticholinergic, Dietary Supplement, Diuretic, Hormone, Anti-Emetic, Bronchodilator, Local Anesthetic, Anemia, Anti-Diarrhea, Antihistamine, Hypotension, Antacid, Anti-Tuberculosis, Insect Repellents, and Laxative. Its Boadent brand includes anticavity dental toothpaste. Its subsidiaries are Balaxi Global DMCC, Dubai and Balaxi healthcare Ecuador.
Employees
500
Date Price Change Volume
01/10/26 ₹22.34 -1.93% 20,508
30/09/26 ₹22.78 -1.04% 11,994
29/09/26 ₹23.02 +2.81% 18,116
28/09/26 ₹22.39 -1.88% 48,102
25/09/26 ₹22.82 +0.40% 11,304
  1. Stock Market
  2. Stocks
  3. BALAXI Stock